REGN - What's Going On With Biohaven Stock Wednesday? | Benzinga
Biohaven Ltd. (NYSE:BHVN) stock is moving lower Wednesday. The company recently presented several updates in different fields such as immunology and oncology at its Annual Investor Research and Development Day.
The Details: The company announced it dosed a patient with a new possible treatment for certain cancers, showcased positive data from two different studies and presented other updates.
Biohaven started the first patient’s treatment in a Phase 1/2 trial for BHV-1510 which includes subjects with select advanced or metastatic epithelial cell tumors.
In addition, Biohaven has entered into a agreement with Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) where Biohaven will ...